Home
About
Overview
Sharing Data
ORCID
Help
History (18)
It's not all about the CNS. High dose methotrexate in DLBCL.
Complications requiring reoperation following vaginal mesh kit procedures for prolapse.
Surgical Outcomes and EEG Prognostic Factors After Stereotactic Laser Amygdalohippocampectomy for Mesial Temporal Lobe Epilepsy.
High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer's disease.
Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit.
Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit. Ageing Res Rev. 2024 Aug; 99:102348.
View in:
PubMed
subject areas
Alzheimer Disease
Antibodies, Monoclonal, Humanized
Humans
authors with profiles
George Perry